Decibel Therapeutics, Inc. Variable Lease, Cost
Decibel Therapeutics, Inc. reported Variable Lease, Cost of $402.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2023-08-11
- Decibel Therapeutics, Inc. variable lease, cost for the quarter ending 2023-06-30 was $201.00K, a 2.55% increase year-over-year.
- Decibel Therapeutics, Inc. variable lease, cost for the quarter ending 2023-03-31 was $201.00K, a 3.08% increase year-over-year.
- Decibel Therapeutics, Inc. variable lease, cost for the quarter ending 2022-12-31 was $196.00K.
- Decibel Therapeutics, Inc. variable lease, cost for the quarter ending 2022-09-30 was $195.00K.
- Decibel Therapeutics, Inc. variable lease, cost for fiscal 2022 was $782.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-06-30 | $201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $402.00K 10-Q · filed 2023-08-11 | $598.00K derived: sum of 3 quarters · filed 2023-08-11 | $793.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $201.00K 10-Q · filed 2023-05-15 | $397.00K derived: sum of 2 quarters · filed 2023-05-15 | $592.00K derived: sum of 3 quarters · filed 2023-05-15 | $788.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $391.00K derived: sum of 2 quarters · filed 2023-03-14 | $587.00K derived: sum of 3 quarters · filed 2023-08-11 | $782.00K 10-K · filed 2023-03-14 |
| 2022-09-30 | $195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $391.00K derived: sum of 2 quarters · filed 2023-08-11 | $586.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $391.00K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $195.00K 10-Q · filed 2023-05-15 |